U.S. Markets open in 4 hrs 50 mins

Largest Insider Trades of the Week

The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to "$200,000+," the duration to "September 2019" and All Insider Sales to "$200,000+."

According to these filters, the following are trades from company insiders this week.


The Tiger Global Long Opportunities Fund bought 859,897 shares of Sunrun Inc. (NASDAQ:RUN) for an average price of $17.24 per share on Sept. 19.

97f9d5d1958e65eb99323022b3767b14.png

The solar energy services provider has a market cap of $2.05 billion and an enterprise value of $4.39 billion. It has insider ownership of 7.18% and institutional ownership of 97.21%.

Over the past 12 months, the stock has risen 39.68% and, as of Friday, was trading 18.49% below its 52-week high and 98.18% above its 52-week low.

Ronald O. Perelman bought 606,061 shares of vTv Therapeutics Inc. (NASDAQ:VTVT) for an average price of $1.65 per share on Sept. 18.

7d0017579366b77bc60b9562e776017d.png

The company, which develops orally administered small molecule drug candidates, has a market cap of $97.28 million and an enterprise value of $106.83 million. It has insider ownership of 0.24% and institutional ownership of 10.07%.

Over the past 12 months, the stock has risen 110% and, as of Friday, was trading 71.62% below its 52-week high and 130.44% above its 52-week low.

Rajeev M. Shah, director and 10% owner, and Ken Takanashi, director, together with 10% owner RA Capital Healthcare Fund LP and TPG Group Holdings (SBS) Advisors bought a combined 2.99 million shares of Satsuma Pharmaceuticals Inc. (STSA) for an average price of $15 per share on Sept. 17.

The clinical-stage biopharmaceutical company has a market cap of $257.88 million and an enterprise value of $207.87 million.

Over the past 12 months, the stock has fallen 8.22%.

Mitchell S. Felder, chairman and 10% owner of Premier Biomedical Inc. (BIEI), bought 1 million shares for an average price of one cent per share on Sept. 16.

a4b0577393ffe69b853429448551957c.png

The specialty drugmaker has a market cap of $220,000 and an insider ownership of 5.75%.

Over the past 12 months, the stock has fallen 94.72% and, as of Friday, was trading 94.83% below its 52-week high and 116% above its 52-week low.

Jorge P. Lemann, director of The Kraft Heinz Co. (NASDAQ:KHC), bought 3.49 million shares for an average price of $28.60 per share on Sept. 16.

b0315294d6aab3f378b8091d393ed428.png

The food and beverage company has a market cap of $34.66 billion and an enterprise value of $64.47 billion. It has institutional ownership of 71.72% and insider ownership of 0.2%.

Over the past 12 months, the stock has fallen 50.60% and, as of Friday, was trading 51.28% below its 52-week high and 13.82% above its 52-week low.

Most important insider sales

Michael Patrick Byrne, 10% owner of Overstock.com Inc. (NASDAQ:OSTK), sold 4.07 million shares for an average price of $19.15 per share on Sept. 18.

95578f31919234954b37597e894a56d5.png

The online retailer has a market cap of $571.33 million and an enterprise value of $574.77 million. It has insider ownership of 6.09% and institutional ownership of 81.35%.

Over the past 12 months, shares have fallen 39.02%. As of Friday, the stock was trading 49.41% below its 52-week high and 67.97% above its 52-week low.

Amanda MK Trust, 10% owner of National Research Corp. (NRC), sold 500,000 shares for an average price of $60.50 per share on Sept. 18.

885f7bc0d13f25a5f88a9d92dc097a98.png

The company, which operates in the medical diagnostics and research industry, has a market cap of $1.57 billion and an enterprise value of $1.60 billion. It has insider ownership of 2.12% and institutional ownership of 57.76%.

Over the past 12 months, the share price has risen 64.71% and, as of Friday, was trading 8.51% below its 52-week high and 77.07% above its 52-week low.

John Kristofer Galashan and Jonathan A. Seiffer sold a combined 6.01 million shares of GMS Inc. (NYSE:GMS) for an average price of $25.68 per share on Sept. 17.

b2effdd26eed60ee41d99c25f53b3253.png

The company has a market cap of $3.59 billion and an enterprise value of $7.38 billion. It has insider ownership of 1.07% and institutional ownership of 77.04%.

Over the past 12 months, the stock has fallen 9.46% and, as of Friday, was trading 11.6% below its 52-week high and 35.99% above its 52-week low.

Disclosure: I do not own any stocks mentioned.

Read more here:



Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.

This article first appeared on GuruFocus.